Medplus Health Financials
NSE: MEDPLUS | BSE: 543427
₹659.70
As on 07-Sep-2026IST
Market cap
₹7,912 Cr
Revenue (TTM)
₹7,229 Cr
P/E Ratio
37.6
P/B Ratio
4
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
7,229.43
|
6,892.47
|
6,136.05
|
5,624.86
|
4,557.58
|
3,779.28
|
|||||
|
Total Income
|
7,305.56
|
6,963.79
|
6,184.67
|
5,664.86
|
4,603.65
|
3,810.64
|
|||||
|
Total Expenditure
|
6,619.55
|
6,268.09
|
5,632.59
|
5,253.56
|
4,276.21
|
3,490.40
|
|||||
|
EBITDA
|
609.88
|
624.38
|
503.47
|
371.30
|
281.37
|
288.88
|
|||||
|
Depreciation
|
295.17
|
282.87
|
249.84
|
224.21
|
181.56
|
119.36
|
|||||
|
EBIT
|
314.71
|
341.51
|
253.62
|
147.08
|
99.81
|
169.52
|
|||||
|
Interest
|
126.40
|
137.50
|
118.95
|
113.65
|
98.72
|
82.94
|
|||||
|
Other Income
|
76.13
|
71.32
|
48.62
|
40.01
|
46.08
|
31.36
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
264.44
|
275.33
|
183.29
|
73.44
|
47.16
|
117.94
|
|||||
|
Provision for Tax
|
54.01
|
55.72
|
33.06
|
7.87
|
-2.94
|
23.23
|
|||||
|
Profit after Tax
|
210.43
|
219.61
|
150.23
|
65.58
|
50.11
|
94.72
|
|||||
|
Minority Interest
|
0.04
|
0.04
|
0.09
|
-0.10
|
-0.34
|
1.09
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
210.47
|
219.65
|
150.32
|
65.47
|
49.76
|
95.80
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
1,975.36
|
1,975.36
|
1,740.56
|
1,577.93
|
1,491.18
|
1,417.77
|
|||||
|
Minority Interest
|
0.04
|
-0.71
|
-0.66
|
-0.57
|
-0.68
|
-0.52
|
|||||
|
Non-Current Liabilities
|
1,268.58
|
1,225.00
|
991.72
|
849.44
|
797.41
|
647.40
|
|||||
|
Current Liabilities
|
689.29
|
763.90
|
624.57
|
574.85
|
476.58
|
559.01
|
|||||
|
Total Liabilities
|
3,932.53
|
4,084.80
|
3,456.02
|
3,086.64
|
2,830.30
|
2,668.61
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
520.92
|
1,820.29
|
1,464.69
|
1,385.18
|
1,283.77
|
991.95
|
|||||
|
Current Assets
|
2,068.65
|
2,143.26
|
1,891.49
|
1,616.46
|
1,480.72
|
1,631.71
|
|||||
|
Total Assets
|
3,932.53
|
4,084.80
|
3,456.02
|
3,086.64
|
2,830.30
|
2,668.61
|
|||||
|
Total Debt*
|
--
|
--
|
--
|
--
|
--
|
142.68
|
|||||
|
Net Current Assets
|
1,379.36
|
1,379.36
|
1,266.92
|
1,041.62
|
1,004.14
|
1,072.70
|
|||||
|
Contingent Liabilities
|
--
|
14.06
|
13.78
|
13.78
|
11.89
|
11.89
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
495.58
|
540.43
|
143.74
|
90.41
|
169.89
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-127.72
|
-317.61
|
-82.80
|
429.44
|
-703.13
|
|||||
|
Cash from Financing Activities
|
--
|
-255.51
|
-227.98
|
-198.10
|
-170.25
|
440.43
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
112.36
|
-5.16
|
-137.17
|
349.60
|
-92.81
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
17.55
|
18.30
|
12.56
|
5.48
|
4.17
|
8.03
|
|||||
|
Cash EPS (₹)
|
17.52
|
41.85
|
33.42
|
24.24
|
19.42
|
17.94
|
|||||
|
Adjusted Book Value (₹)
|
166.52
|
163.87
|
143.22
|
129.47
|
122.44
|
117.89
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
41.28
|
45.15
|
12.02
|
7.58
|
14.24
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
23.34
|
32.52
|
-2.15
|
-12.78
|
-0.50
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
22.22
|
18.22
|
12.19
|
9.56
|
16.56
|
|||||
|
ROE (%)
|
11.02
|
11.93
|
9.21
|
4.36
|
3.50
|
9.07
|
|||||
|
ROA (%)
|
5.77
|
6.00
|
4.73
|
2.27
|
1.86
|
4.51
|
|||||
|
EBIT Margin (%)
|
4.35
|
4.95
|
4.13
|
2.61
|
2.19
|
4.49
|
|||||
|
Net Margin (%)
|
2.88
|
3.15
|
2.43
|
1.16
|
1.09
|
2.49
|
|||||
|
Cash Profit Margin (%)
|
--
|
7.19
|
6.43
|
5.08
|
5.01
|
5.59
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
16.79
|
12.33
|
9.09
|
23.42
|
20.59
|
23.13
|
|||||
|
EBIT Growth (%)
|
17.15
|
34.65
|
72.44
|
47.36
|
-41.12
|
20.27
|
|||||
|
Net Profit Growth (%)
|
18.03
|
46.18
|
129.09
|
30.88
|
-47.10
|
50.08
|
|||||
|
EPS Growth (%)
|
17.77
|
45.68
|
129.29
|
31.32
|
-48.06
|
-97.18
|
|||||
|
Book Value Growth (%)
|
--
|
14.76
|
10.77
|
5.94
|
3.87
|
106.24
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
37.59
|
45.79
|
60.48
|
125.87
|
156.11
|
125.80
|
|||||
|
Price / Book Value
|
3.96
|
5.11
|
5.30
|
5.33
|
5.32
|
8.57
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
10.86
|
13.79
|
15.80
|
19.69
|
22.86
|
37.97
|
|||||
|
Close Price (₹)
|
810.75
|
839.90
|
760.00
|
687.85
|
649.70
|
1,014.50
|
|||||
|
High Price (₹)
|
1,022.20
|
1,052.05
|
876.75
|
978.00
|
1,049.00
|
1,343.00
|
|||||
|
Low Price (₹)
|
731.95
|
603.00
|
615.55
|
597.95
|
548.25
|
921.00
|
|||||
|
Market Cap (₹ Cr)
|
7,912.23
|
10,057.49
|
9,091.18
|
8,241.54
|
7,768.39
|
12,052.28
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
--
|
--
|
--
|
0.10
|
|||||
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
--
|
0.10
|
|||||
|
Current Ratio
|
3.00
|
2.81
|
3.03
|
2.81
|
3.11
|
2.92
|
|||||
|
Quick Ratio
|
1.00
|
1.00
|
0.87
|
0.48
|
0.71
|
1.28
|
|||||
|
Interest Coverage
|
3.09
|
3.00
|
2.54
|
1.65
|
1.48
|
2.42
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
0.37
|
0.39
|
0.22
|
0.31
|
0.19
|
0.16
|
|||||
|
Asset Turnover
|
1.98
|
1.91
|
1.96
|
1.98
|
1.72
|
1.83
|
|||||
|
Receivable days
|
--
|
1.05
|
0.90
|
0.84
|
0.58
|
0.54
|
|||||
|
Inventory Days
|
--
|
71.25
|
78.76
|
79.52
|
81.27
|
79.28
|
|||||
|
Payable days
|
--
|
21.75
|
21.71
|
21.33
|
25.98
|
24.13
|
|||||
|
Cash Conversion Cycle
|
--
|
50.55
|
57.95
|
59.03
|
55.87
|
55.69
|